DUBAI, UNITED ARAB EMIRATES--(Marketwired - Feb 20, 2014) - Global Equity International, Inc. (OTCQB: GEQU) and its fully owned subsidiary Global Equity Partners Plc., a specialist consultancy firm with offices located in Dubai and London is pleased to announce that today the Company has signed a contract and agreed on a strategy with Medinas Holding BV, to assist with taking the Company to the public markets of Dubai (NASDAQ Dubai).
Medinas Holding BV represents companies that have patented medical procedures and a fully integrated system that have allowed them to become the market leaders in the field of treating cancer. The treatment methods are FDA approved and CE registered. The Company is currently distributing their solution throughout the USA, Europe and the Middle East. This patented medical procedure is specifically designed and manufactured for use in abdominal surgery for peritoneal cancer. It is a treatment that is delivered directly into the abdomen. This leap forward in medical innovation in the fight against cancer has been welcomed by the global medical community.
The Company's CEO expressed the following: "We are excited to now move further into the international market with these treatments. This is the next step in our strategic plan as we position our company as the international leader in thermal medicine. Global Equity International, Inc. and its subsidiary Global Equity Partners Plc have mutually executed an agreement with Medinas Holding BV and are excited to assist with launching Medinas Holding BV onto the Dubai stock exchange. Global Equity Partners Plc. will lead the strategic plan on structure, development and formation in the United Arab Emirates. Medinas Holding BV plans to be based in Dubai where they will lead the regional sales and marketing and also an education division for this innovative procedure."
Peter Smith, CEO of Global Equity International Inc., commented: "We have been negotiating with Medinas Holding BV, a Dutch limited company, for many months now and we are delighted that the company has retained our services hence made the decision to list their company on a public exchange. The company owns an FDA approved and CE registered patented medical procedure along with a fully integrated system specifically designed and manufactured for use in abdominal surgery for peritoneal cancer. This know-how (procedure) and system will, in our opinion, will turn the Company into a global leader in the field of peritoneal cancer treatment and we believe that a client of this calibre will have a very positive effect on our Company as well hence we are very proud to become part of such an innovative advance in medical science."
About Global Equity International Inc. (OTCQB: GEQU) and subsidiary Global Equity Partners Plc.:
With offices located in Dubai and London, Global Equity Partners Plc. advises worldwide business leaders with their most critical decisions and opportunities pertaining to growth, capital needs, structure and the development of a global presence. With significant relationships in USA, UK, Central Europe, the Middle East and South East Asia, we assist our clients with finding their true potential by bringing to them external capital and resources that place an emphasis on collaborative thinking. With a physical presence in DUBAI, we introduce our clients to the unique opportunity of becoming listed on the NASDAQ Dubai Exchange. The NASDAQ Dubai offers exciting opportunities for newly listed companies with exposure to a large reservoir of registered funding agents and wealthy individuals looking to enhance their portfolios with the very best companies Global Equity Partners Plc. has to offer.
This press release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to anticipated revenues, expenses, earnings, operating cash flows, the outlook for markets and the demand for products. Forward-looking statements are not guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statements. Such statements are based upon, among other things, assumptions made by, and information currently available to, management, including management's own knowledge and assessment of the Company's industry and competition. The Company refers interested persons to its most recent Annual Report on Form 10-K and its other SEC filings for a description of additional uncertainties and factors, which may affect forward-looking statements. The Company assumes no duty to update its forward-looking statements.